ADVFN Logo ADVFN

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Phio Pharmaceuticals Corporation

Phio Pharmaceuticals Corporation (PHIO)

1.30
-0.04
(-2.99%)
Cerrado 09 Marzo 2:00PM
1.34
0.04
(3.08%)
Fuera de horario: 6:31PM
Gráfico avanzado

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
1.34
Postura de Compra
1.25
Postura de Venta
1.44
Volume Operado de la Acción
92,172
1.26 Rango del Día 1.37
1.2201 Rango de 52 semanas 9.99
Capitalización de Mercado [m]
Precio Anterior
1.34
Precio de Apertura
1.3525
Última hora de negociación
Volumen financiero
US$ 121,205
Precio Promedio Ponderado
1.315
Volumen promedio (3 m)
7,284,573
Acciones en circulación
1,055,219
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.13
Beneficio por acción (BPA)
-10.26
turnover
-
Beneficio neto
-10.83M

Acerca de Phio Pharmaceuticals Corporation

Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipelin... Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipeline products include PH-762, PH-804, PH-790, and others. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
Sede
Camden, Delaware, USA
Fundado
-
Phio Pharmaceuticals Corporation is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PHIO. The last closing price for Phio Pharmaceuticals was US$1.34. Over the last year, Phio Pharmaceuticals shares have traded in a share price range of US$ 1.2201 to US$ 9.99.

Phio Pharmaceuticals currently has 1,055,219 shares in issue. The market capitalisation of Phio Pharmaceuticals is US$1.41 million. Phio Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.13.

PHIO Últimas noticias

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.11-7.586206896551.451.451.22011675191.35668944CS
4-0.72-34.95145631072.062.061.22012041171.64619508CS
12-1.53-53.31010452962.879.791.220172845735.48529475CS
26-1.34-502.689.791.220132356075.45709341CS
52-7.12-84.16075650128.469.991.220116805505.53298046CS
156-86.14-98.468221307787.48261.361.2201108731365.06989125CS
260-325.9-99.590514607327.24699.841.2201944030129.83522854CS

PHIO - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Phio Pharmaceuticals?
El precio actual de las acciones de Phio Pharmaceuticals es US$ 1.34
¿Cuántas acciones de Phio Pharmaceuticals están en circulación?
Phio Pharmaceuticals tiene 1,055,219 acciones en circulación
¿Cuál es la capitalización de mercado de Phio Pharmaceuticals?
La capitalización de mercado de Phio Pharmaceuticals es USD 1.41M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Phio Pharmaceuticals?
Phio Pharmaceuticals ha negociado en un rango de US$ 1.2201 a US$ 9.99 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Phio Pharmaceuticals?
El ratio precio/beneficio de Phio Pharmaceuticals es -0.13
¿Cuál es la moneda de reporte de Phio Pharmaceuticals?
Phio Pharmaceuticals presenta sus resultados financieros en USD
¿Cuál es el último beneficio anual de Phio Pharmaceuticals?
El último beneficio anual de Phio Pharmaceuticals es USD -10.83M
¿Cuál es la dirección registrada de Phio Pharmaceuticals?
La dirección registrada de Phio Pharmaceuticals es 2140 S DUPONT HWY, CAMDEN, DELAWARE, 19934
¿Cuál es la dirección del sitio web de Phio Pharmaceuticals?
La dirección del sitio web de Phio Pharmaceuticals es www.phiopharma.com
¿En qué sector industrial opera Phio Pharmaceuticals?
Phio Pharmaceuticals opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ABLVAble View Global Inc
US$ 1.73
(137.18%)
5.14M
SUNESUNation Energy Inc
US$ 0.402999
(127.55%)
482.05M
BTOGBit Origin Ltd
US$ 0.6117
(118.46%)
622.67M
DWTXDogwood Therapeutics Inc
US$ 6.63
(49.66%)
25.92M
KZIAKazia Therapeutics Ltd
US$ 1.1899
(40.80%)
4.5M
ALBTAvalon GloboCare Corporation
US$ 6.96
(-36.15%)
577.55k
SCNXScienture Holdings Inc
US$ 1.55
(-35.68%)
1.59M
ACXPAcurx Pharmaceuticals Inc
US$ 0.4572
(-29.88%)
1.18M
RETOReTo Eco Solutions Inc
US$ 5.42
(-27.73%)
108.27k
OCTOEightco Holdings Inc
US$ 1.08
(-27.03%)
336.99k
BTOGBit Origin Ltd
US$ 0.6117
(118.46%)
622.67M
SUNESUNation Energy Inc
US$ 0.402999
(127.55%)
482.05M
NVDANVIDIA Corporation
US$ 112.69
(1.92%)
341.94M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10.675
(-0.70%)
143.04M
ICONIcon Energy Corporation
US$ 0.169898
(17.17%)
142.23M

PHIO Finanzas

Finanzas

PHIO Discussion

Ver más
subslover subslover 7 horas hace
Spuds! Absolutely! Nobody pays much attention to this when its going down but they chase it every time it pops. This is a great one short-term and long🤭
👍️0
subslover subslover 7 horas hace
I always like your analytics. Just wait, many will come back strong!😁
👍️0
Spuds McKenz66 Spuds McKenz66 11 horas hace
YA BIG TIME , RUNNING AROUND NAKED IN THE SNOW , WANT A PICTURE? PHIO
👍️0
Spuds McKenz66 Spuds McKenz66 11 horas hace
20/30 cents coming PHIO MEOW
👍️0
Spuds McKenz66 Spuds McKenz66 11 horas hace
phio is the bomb
👍️0
Monksdream Monksdream 14 horas hace
This is another med sector of over 450 issues
https://www.barchart.com/stocks/quotes/CRSP/competitors?quoteSectors=-283G&viewName=main&orderBy=weightedAlpha&orderDir=desc
The burning question going forward is have a lot of stocks reached absolute bottom?
👍️0
Monksdream Monksdream 14 horas hace
The broader med sectors have been in a bear market for months
This link to a Barchart webpage has a sector chart for 147:issues, including PHIO
https://www.barchart.com/stocks/quotes/PSTV/competitors?quoteSectors=-MEDR&viewName=main&orderBy=weightedAlpha&orderDir=desc
Provides ample evidence
👍️ 1 😴 1
subslover subslover 14 horas hace
Way oversold! All it will take is one fairly meaty PR and BANG ZOOM!😷
👍️0
Monksdream Monksdream 15 horas hace
PHIO under $2
👍️0
subslover subslover 19 horas hace
I think PHIO is due for a pop! She has a minimal public float!😍😇
👍️0
Spuds McKenz66 Spuds McKenz66 4 días hace
Nice PHIO
👍️0
subslover subslover 4 días hace
Phio Pharmaceuticals Announces Completion of Enrollment in Third Safety Cohort in PH-762 Phase 1b Dose-Escalation Study
Newsfile Corp.
Newsfile Corp
Marlborough, Massachusetts--(Newsfile Corp. - March 5, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company developing therapeutics that use its INTASYL® siRNA gene silencing technology designed to make the body's immune cells more effective in killing cancer cells. Phio announced today that it has fulfilled the required enrollment for safety in its third dose cohort in its Phase 1b dose escalating clinical study for their lead compound PH-762. The company plans to initiate screening of the fourth dose cohort in early April.

Phio's Phase 1b study (NCT 06014086) is a multi-center, dose-escalating clinical trial designed to evaluate the safety and tolerability of neoadjuvant use of intratumoral PH-762 in cutaneous squamous cell carcinoma, melanoma, or Merkel cell carcinoma. This study assesses the tumor response and determines the recommended dose for further study of PH-762.

"We are excited with the rapid completion of enrollment of the third safety cohort," said Robert Bitterman, CEO of Phio Pharmaceuticals. "We look forward to rapidly advancing the study to bring an innovative, alternative treatment option to patients with skin carcinomas."
👍️0
PonkenPlonken PonkenPlonken 2 semanas hace
funny anecdote
this one gave ALNY the schvitz in 2010 because of the IP around RNAi conjugation.
Needless to say thats not the case anymore.
Just goes to show they know exxactly what they are doing with this scam.
👍️0
subslover subslover 2 semanas hace
OT: I know you are bro🤑 and you need to keep a close tab on RNAZ she is dropping like a rock today. Anything under $ 5.00 is child's play!
👍️0
Spuds McKenz66 Spuds McKenz66 2 semanas hace
ya I'm in just kidding around we are solid , got a boat load of money
👍️0
subslover subslover 2 semanas hace
Do you want😍 to join me?😋😇😁
👍️0
Spuds McKenz66 Spuds McKenz66 2 semanas hace
1.65 lol u clown sell dip douche
👍️0
subslover subslover 2 semanas hace
$1.44 new 52-week low. Bought $1.47 on my double down. 😇
👍️0
subslover subslover 2 semanas hace
Currently, $1.57 nearing its 52-week low of $1.53. Should she drop under $1.50 I'm doubling down.😷
👍️0
subslover subslover 4 semanas hace
Grabbed $1.79♥️
👍️0
subslover subslover 1 mes hace
Very nice indeed! I am still holding that other half from the last time it ran. This Company I like long term as well🤩
👍️0
tw0122 tw0122 1 mes hace
$2.20 now ..Picked up $1.90s yesterday and flipped out at $2.60s this morning. Going to grab some more on the new dump for next flip $1.90- 2.20 should be good buying zone today 
👍️0
subslover subslover 2 meses hace
Let it get sloppy like last time. 🤣
👍️0
Zilidium Zilidium 2 meses hace
S-1 Does the forecast call for pain...

Pros: If PHIO demonstrates strong progress in its clinical trials, communicates a clear and effective use of proceeds, and generates positive clinical and financial milestones, the additional 5.9 million shares is a reasonable trade-off for long-term growth.

Cons: If there’s limited progress (no reason to believe there will be with the recent news) delays, or ambiguity about the company’s ability to monetize its pipeline, the market may view the dilution as detrimental, which will be bad, very, very bad indeed.

When will the warrants expire??

Series E Warrants: Exercisable until December 2029 @ $2.51
Series F Warrants: Exercisable until December 2029 @ 2.00
Series G, H, and I Warrants: Exercisable until January 2027 $3.00
Warrants must be exercised voluntarily, and holders typically do so when the market price exceeds the warrant exercise price.

This may get sloppy, so hold on.

👍️0
Invest-in-America Invest-in-America 2 meses hace
PHIO: We are all LONG-GONE with our PROFITS, Dude!!! (Thank you, PHIO company!!!!)
👍️0
peterus peterus 2 meses hace
lol told you new offering 
👍️0
Invest-in-America Invest-in-America 2 meses hace
PHIO: See ME, below, workin' on that $10.00, right now!!!

"PLEASE, Oh Lord, give me $10.00 even on PHIO today, & I'll donate 50% of my profits to THE STARVATION ARMY, and SAINT JUDE'S CHILDREN'S REFORMATORY!!"
👍️0
subslover subslover 2 meses hace
Yea buddy great call on your part here! I flipped out 1/2 of my position at the same price as you!♥️
👍️0
peterus peterus 2 meses hace
hope you see that $10 bro 
👍️0
Invest-in-America Invest-in-America 2 meses hace
PHIO: Heck, now look at what you just made me do with your post, Dude!! (That's me LIVE, below, right NOW via my San Diego KITCHEN-CAM!!!)

😂 1
crudeoil24 crudeoil24 2 meses hace
Company has multiple Form 424B5 - Prospectus [Rule 424(b)(5)]
Last few months
👍️0
peterus peterus 2 meses hace
it a dilution pos bro offering...offering 
👍️0
tw0122 tw0122 2 meses hace
Mostly out $4.30s thanks for tips..SENS could reclaim $2s on the 3 year has some work. TNXP has a nice bottom chart
👍️0
Invest-in-America Invest-in-America 2 meses hace
PHIO: Ten bucks easy today. (I will kick-back now, & relax.)
👍️0
Invest-in-America Invest-in-America 2 meses hace
PHIO: Don't think they'll Halt it --- volume still very low.
👍️0
tw0122 tw0122 2 meses hace
Took some off $3.80s before the halt comes 
👍️0
Invest-in-America Invest-in-America 2 meses hace
PHIO: And it did just THAT!!
👍️0
tw0122 tw0122 2 meses hace
One step at a time says humankind. Blow those $3.29s we rocket launch 🚀 to Jupiter 
👍️0
Invest-in-America Invest-in-America 2 meses hace
PHIO: They had GREAT news few days ago!! (Rarely hear anything great about CANCER.)
👍️0
Invest-in-America Invest-in-America 2 meses hace
PHIO: Could have $5.00 here today.
👍 1
tw0122 tw0122 2 meses hace
Small offerings with excellent news are ok $3.14
👍️0
subslover subslover 2 meses hace
The offering was small. IMHO I think many got trapped on the 400% run and dumped for a loss. 😷
👍️0
tw0122 tw0122 2 meses hace
$2.72 gone green offering absorbed now. Let's see what happens next $6- $8 targets 
👍️0
subslover subslover 2 meses hace
Beautiful!🤩
👍️0
tw0122 tw0122 2 meses hace
Grabbed $2.40s
👍️0
subslover subslover 2 meses hace
$2.41 low so far. Don't forget what I said about the $2.25 mark. I can only hope.🤗
👍️0
Invest-in-America Invest-in-America 2 meses hace
PHIO: And the RED INK continues!! (But then, hopefully tomorrow they PR a proven Phase-3 CURE for every Cancer known to MANKIND!!!)


"Well, we're WAITING --- for your NEXT wonderful Cancer cure PR, oh great PHIO Company!!! And, will ya DUMP more shares to Market, the DAY thereafter???!!! We sincerely HOPE NOT!!!"
👍️0
Invest-in-America Invest-in-America 2 meses hace
PHIO: Very WELL-STATED, Dude!! (Nothing more needed to be posted here, by anybody.)
👍️0
Invest-in-America Invest-in-America 2 meses hace
PHIO: Much more apropos would be, "Severely over-DUMPED-to-Market", by the Company itself!!! (Heck, they should pay their great Anti-Cancer RESEARCHERS and/or drug MAKERS to orchestrate their next news & PR's!!!)
👍️0
subslover subslover 2 meses hace
If it drops to $2.25 I will wire $$$$$ funds to my brokerage account!🤣
👍️0